Maria Salazar
Family · Downey, CANPI 1356412639
Payments from drug & device makers
Across 27 payments — averaging $69.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$1K
- Abbott$617
- Atricure, Inc.$37
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$36
- Viiv Healthcare Company$30
- Optinose US, Inc.$19
- plus $49 from 3 others
What the payments were for
- Travel & lodging$91749%
- Food & beverage$95851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 10 | $1,087 |
| Abbott | 8 | $617 |
| Atricure, Inc. | 1 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $36 |
| Viiv Healthcare Company | 1 | $30 |
| Optinose US, Inc. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclose Maven Catheter$834
- Epic$326
- PORTICO$174
How this compares
$1,875 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 36 | $44,240 |
| OzempicSemaglutide | 25 | $34,515 |
| JardianceEmpagliflozin | 22 | $28,204 |
| EliquisApixaban | 16 | $20,193 |
| FarxigaDapagliflozin Propanediol | 13 | $15,723 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $9,105 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $5,552 |
| MyrbetriqMirabegron | 11 | $5,068 |
| Humalog Kwikpen U-100Insulin Lispro | 18 | $4,759 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $4,228 |
| LantusInsulin Glargine,hum.Rec.Anlog | 17 | $4,033 |
| Atorvastatin Calcium | 274 | $2,557 |
| Losartan Potassium | 183 | $2,252 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 83 | $1,971 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 21 | $1,907 |
Paid to pharmacies, not to this prescriber.
Other family in Downey
- Anais LaneDowney$25K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.